ReviewCells2021

Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy.

Ji Woong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.